These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 27213264)

  • 41. Bordetella pertussis from functional genomics to intranasal vaccination.
    Locht C; Antoine R; Raze D; Mielcarek N; Hot D; Lemoine Y; Mascart F
    Int J Med Microbiol; 2004 Apr; 293(7-8):583-8. PubMed ID: 15149035
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pertussis in Argentina and France.
    Caro V; Bouchez V; Guiso N; Gatti B; Agosti MR; Ayala SE
    Vaccine; 2007 May; 25(22):4335-9. PubMed ID: 17229502
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is pertussis a frequent cause of cough in adolescents and adults? Should routine pertussis immunization be recommended?
    Edwards KM
    Clin Infect Dis; 2001 Jun; 32(12):1698-9. PubMed ID: 11360209
    [No Abstract]   [Full Text] [Related]  

  • 44. Attenuated Bordetella pertussis BPZE1 as a live vehicle for heterologous vaccine antigens delivery through the nasal route.
    Li R; Lim A; Alonso S
    Bioeng Bugs; 2011; 2(6):315-9. PubMed ID: 22067832
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bordetella pertussis, B. parapertussis, vaccines and cycles of whooping cough.
    Bouchez V; Guiso N
    Pathog Dis; 2015 Oct; 73(7):. PubMed ID: 26242280
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bordetella pertussis: why is it still circulating?
    Guiso N
    J Infect; 2014 Jan; 68 Suppl 1():S119-24. PubMed ID: 24103807
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence?
    Mooi FR; van Loo IH; King AJ
    Emerg Infect Dis; 2001; 7(3 Suppl):526-8. PubMed ID: 11485646
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bordetella pertussis Isolates Circulating in China Where Whole Cell Vaccines Have Been Used for 50 Years.
    Wang Z; He Q
    Clin Infect Dis; 2015 Sep; 61(6):1028-9. PubMed ID: 26060284
    [No Abstract]   [Full Text] [Related]  

  • 49. Analysis of Bordetella pertussis populations in European countries with different vaccination policies.
    van Amersfoorth SC; Schouls LM; van der Heide HG; Advani A; Hallander HO; Bondeson K; von König CH; Riffelmann M; Vahrenholz C; Guiso N; Caro V; Njamkepo E; He Q; Mertsola J; Mooi FR
    J Clin Microbiol; 2005 Jun; 43(6):2837-43. PubMed ID: 15956406
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Population dynamics and antigenic drift of
    Mir-Cros A; Moreno-Mingorance A; Martín-Gómez MT; Codina G; Cornejo-Sánchez T; Rajadell M; Van Esso D; Rodrigo C; Campins M; Jané M; Pumarola T; Fàbrega A; González-López JJ
    Emerg Microbes Infect; 2019; 8(1):1711-1720. PubMed ID: 31769735
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada.
    Tsang RS; Lau AK; Sill ML; Halperin SA; Van Caeseele P; Jamieson F; Martin IE
    J Clin Microbiol; 2004 Nov; 42(11):5364-7. PubMed ID: 15528744
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serospecific protection of mice against intranasal infection with Bordetella pertussis.
    Robinson A; Gorringe AR; Funnell SG; Fernandez M
    Vaccine; 1989 Aug; 7(4):321-4. PubMed ID: 2573215
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of pertussis toxin encoded by ptx genes from Bordetella bronchiseptica to model the effects of antigenic drift of pertussis toxin on antibody neutralization.
    Hausman SZ; Burns DL
    Infect Immun; 2000 Jun; 68(6):3763-7. PubMed ID: 10816544
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protective activities of "Bordetella pertussis" Tn5 mutants in mice.
    Olander RM; Muotiala A; Parviainen T; Runeberg-Nyman K
    Ann Sclavo Collana Monogr; 1986; 3(1-2):329-35. PubMed ID: 2892513
    [No Abstract]   [Full Text] [Related]  

  • 55. [Global pertussis epidemiology and immunization strategies].
    Zhang WH
    Zhongguo Yi Miao He Mian Yi; 2009 Oct; 15(5):467-72. PubMed ID: 20084979
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Highlights of the 11th International Bordetella Symposium: from Basic Biology to Vaccine Development.
    Carbonetti NH; Wirsing von König CH; Lan R; Jacob-Dubuisson F; Cotter PA; Deora R; Merkel TJ; van Els CA; Locht C; Hozbor D; Rodriguez ME
    Clin Vaccine Immunol; 2016 Nov; 23(11):842-850. PubMed ID: 27655886
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Screening and Genomic Characterization of Filamentous Hemagglutinin-Deficient Bordetella pertussis.
    Weigand MR; Pawloski LC; Peng Y; Ju H; Burroughs M; Cassiday PK; Davis JK; DuVall M; Johnson T; Juieng P; Knipe K; Loparev VN; Mathis MH; Rowe LA; Sheth M; Williams MM; Tondella ML
    Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29358336
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genomic Sequencing of Bordetella pertussis for Epidemiology and Global Surveillance of Whooping Cough.
    Bouchez V; Guglielmini J; Dazas M; Landier A; Toubiana J; Guillot S; Criscuolo A; Brisse S
    Emerg Infect Dis; 2018 Jun; 24(6):988-994. PubMed ID: 29774847
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Why do pertussis vaccines fail?
    Cherry JD
    Pediatrics; 2012 May; 129(5):968-70. PubMed ID: 22529282
    [No Abstract]   [Full Text] [Related]  

  • 60. Surveillance of pertussis: methods and implementation.
    Guiso N; Wirsing von König CH
    Expert Rev Anti Infect Ther; 2016 Jul; 14(7):657-67. PubMed ID: 27224518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.